This HTML5 document contains 219 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n9http://dx.doi.org/10.1001/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q89693629
rdf:type
wikibase:Item
schema:description
artigo científico 2020年学术文章 artykuł naukowy 2020年學術文章 scientific article published on 13 February 2020 artigo científico 2020年學術文章 наукова стаття, опублікована в лютому 2020 2020年学术文章 мақолаи илмӣ scienca artikolo научна статия artículu científicu 2020年学术文章 naučni članak vetenskaplig artikel bài báo khoa học article científic artikel ilmiah מאמר מדעי tieteellinen artikkeli 2020 nî lūn-bûn artikull shkencor 2020年学术文章 2020年學術文章 επιστημονικό άρθρο article scientifique научни чланак 2020年學術文章 artigo científico 2020年の論文 2020年學術文章 bilimsel makale scientific article published on 13 February 2020 ১৩ ফেব্রুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published on 13 February 2020 vedecký článok wissenschaftlicher Artikel научная статья 2020年学术文章 vitskapeleg artikkel wetenschappelijk artikel teaduslik artikkel مقالة علمية نشرت في 13 فبراير 2020 artículo científico publicado en 2020 სამეცნიერო სტატია article scientific tudományos cikk articolo scientifico artikulong pang-agham 2020年学术文章 2020년 논문 vitenskapelig artikkel vědecký článek научни чланак videnskabelig artikel udgivet 13. februar 2020 articol științific บทความทางวิทยาศาสตร์
p:P577
wds:Q89693629-32DBF6AA-9697-466D-B6A3-C5579E4D34C3
wdt:P577
2020-02-13T00:00:00Z
p:P2860
wds:Q89693629-475C4EA9-5567-48CD-A8CA-8617782879C3 wds:Q89693629-566C84C4-3BF4-4B92-91E0-0040C7196E65 wds:Q89693629-37739CCE-A742-41FC-A99E-5597BF9F9873 wds:Q89693629-72BA93A7-1139-465C-A540-A821AFDE3BD9 wds:Q89693629-6EA434A7-C7AB-424E-BC6E-C7260126E2E4 wds:Q89693629-22680151-D14B-435B-9185-DF372D4C8A0C wds:Q89693629-1A1DE2AA-D89D-42C4-AF20-773B3D199176 wds:Q89693629-20991FE9-5EA1-4455-862D-796DC55BA4B4 wds:Q89693629-C4B38CC7-EE41-4BD5-ADD9-948B8673738C wds:Q89693629-B5D722B2-E846-48DF-B90C-8AAD804670E8 wds:Q89693629-BA6A6D11-1371-4297-A8BB-2731542DB185 wds:Q89693629-D627D5DA-1765-4925-8808-F303CB6B7B67 wds:Q89693629-D6F21969-8682-4A6C-8C0F-01588435FAB2 wds:Q89693629-D0BC09B8-75CA-4445-ADE6-2B537BF6212D wds:Q89693629-9667D441-69B7-44EA-B699-9BD01C837444 wds:Q89693629-751D3140-E4E7-4174-BEDD-E7FE68FFFF96 wds:Q89693629-8590B2FD-51B2-4631-A73C-BB2BA67D939A wds:Q89693629-AD5B2549-053A-4987-8B47-DE002822DBFC wds:Q89693629-AD8C2038-0FE3-4A7A-A3BB-98DDF18913C6 wds:Q89693629-AFBDC02B-EF0F-40D4-9942-63B06FB6D506 wds:Q89693629-F0ADC5B3-80EC-4711-B01C-91B7C7E39715 wds:Q89693629-DF1AC1F3-E38E-4CD4-AE42-1853C9566DF9 wds:Q89693629-FE0AB194-4B08-41ED-B9C6-24D5E37159DF
wdt:P2860
wd:Q26748691 wd:Q37601722 wd:Q29619399 wd:Q37496425 wd:Q50666942 wd:Q47579286 wd:Q60682637 wd:Q37601709 wd:Q52646161 wd:Q47705923 wd:Q37627005 wd:Q34538363 wd:Q47322152 wd:Q38734804 wd:Q33262104 wd:Q35892395 wd:Q39615516 wd:Q38393045 wd:Q28244849 wd:Q60682641 wd:Q47308042 wd:Q38188183 wd:Q37953783
p:P2093
wds:Q89693629-17EFD97A-AB60-4E0C-8BB4-7F8EA7BA772C wds:Q89693629-2B8FD46E-5303-4BC7-A593-B68702A625BE wds:Q89693629-2E43F011-C8BD-49C3-B46B-9B68B780470E wds:Q89693629-DAB1810C-4D38-46D6-AF5E-FDE744839475 wds:Q89693629-E930907B-91D9-4A4D-8328-C115D577328D wds:Q89693629-8190F504-823B-4FF0-9E04-15DC8502EC25 wds:Q89693629-93D18AEF-3A84-4EFD-BE43-4F45BA69E518 wds:Q89693629-A1268208-D7D9-4F76-AE3D-6761BEC566CE wds:Q89693629-9F082330-89E7-4415-8F17-28C8FA543953 wds:Q89693629-C953D38E-6891-4196-9128-F56828EB72E4 wds:Q89693629-BC7F40D2-E8C8-4448-A1BD-F9581B68E2F7 wds:Q89693629-BEF2A046-DF1E-497C-AFC7-A8131FA51479 wds:Q89693629-D932D920-6859-4E5D-A829-CFC0AE1C5237
wdt:P2093
A Jo Chien Melanie Majure Anne Wallace Jeffrey B Matthews Ronald N Cohen Laura van 't Veer Marie C Lee Anthony Elias Rebecca Shatsky Catherine Parker Amy Wilson Heather Han Ashish Sanil
rdfs:label
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
skos:prefLabel
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
schema:name
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
p:P50
wds:Q89693629-9C7F9904-4406-472D-B60E-38C3BE4B7BEB wds:Q89693629-A121EED7-744E-4530-AF09-F4A6E39978E2 wds:Q89693629-B327BF13-BFD5-427F-838E-6C3E64A1AA57 wds:Q89693629-87F01B86-6C6D-4B44-9CF6-7FDDB667B83F wds:Q89693629-8FBD40D5-2D26-4188-BA82-6181D0DCAF81 wds:Q89693629-9AA88D26-0647-435B-A287-D33DA33656FE wds:Q89693629-D17DCF21-4063-4227-BC4E-5F47E4C07140 wds:Q89693629-D2107E10-BF62-409C-90D5-333AF1AB148F wds:Q89693629-D286928D-0289-449D-9F53-EC6243164590 wds:Q89693629-B383C52F-2740-46FF-9B37-0D6030282B3E wds:Q89693629-BC353421-707C-4BA2-973D-16EA6C216370 wds:Q89693629-F2444864-E1CD-40D9-B579-C36D6116735D wds:Q89693629-F701EF1C-2EC0-46F5-AFF5-A536CE30BAF8 wds:Q89693629-F7AF39AB-F3F0-4962-85B5-F45E73AF6F84 wds:Q89693629-F8229BAF-8544-4C71-9AAC-8D559867F43D wds:Q89693629-FA2964FB-99B4-4A4D-A2AB-A90BCC94338C wds:Q89693629-E7ACD0A2-EE5F-42F7-9CB0-49D18DB4769C wds:Q89693629-EBC116BD-39F5-4B31-A90D-7306BA37FE05 wds:Q89693629-20EFD9CE-DE45-4512-A727-57DF55214D0B wds:Q89693629-259511F5-4CB7-4BE9-B344-E5E553835079 wds:Q89693629-06F6B822-B217-413B-9415-19A4FB575176 wds:Q89693629-0C0D3DCC-95DF-41C6-8473-A68B50517B27 wds:Q89693629-15C6F4C5-D089-45ED-9FE3-E3183079320E wds:Q89693629-65D2506C-4C76-4092-A03D-9D6E26A61276 wds:Q89693629-6F7B0B17-ED48-4D7B-8532-F2F3B2D3CF5E wds:Q89693629-722EDDD0-51CC-4421-AF6C-E6D7A2669D19 wds:Q89693629-72F16091-3C63-4C87-99EF-28E05E8A5801 wds:Q89693629-2F0F9246-2D5D-470C-9D3D-B1C5AD2FA5BD wds:Q89693629-3ABF2508-C2C1-4099-806E-864AED2611F2 wds:Q89693629-4FCECC57-12B5-4C1F-8813-B899D46DEF29 wds:Q89693629-53A7915D-EC53-46C8-B989-200124044E9F
wdt:P50
wd:Q92381506 wd:Q88627844 wd:Q91187033 wd:Q90317078 wd:Q90579511 wd:Q88683050 wd:Q91960202 wd:Q91183705 wd:Q101216517 wd:Q102133653 wd:Q91374943 wd:Q117271109 wd:Q117271110 wd:Q117271100 wd:Q117271108 wd:Q116996320 wd:Q117232925 wd:Q55975497 wd:Q117271112 wd:Q89668739 wd:Q117271114 wd:Q91071545 wd:Q73566215 wd:Q91728213 wd:Q40959832 wd:Q93242959 wd:Q87838438 wd:Q117271113 wd:Q92576217 wd:Q114338711 wd:Q56985470
p:P1476
wds:Q89693629-11D5D639-919D-4E7A-9FC2-139F4BB8D72E
wdt:P1476
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
p:P31
wds:Q89693629-7420ABD3-7C73-4650-A479-F6CA62E3F0B6
wdt:P31
wd:Q13442814
p:P921
wds:Q89693629-6E9EE3BF-FFF9-47B0-BD98-37B27FF24C65 wds:Q89693629-19226652-C7E8-4883-A165-1075E202F0B0
wdt:P921
wd:Q13896859 wd:Q42824440
p:P698
wds:Q89693629-CCC5875A-8A07-4F26-A262-B7B32FD602E3
wdtn:P698
n10:32053137
wdt:P698
32053137
p:P1433
wds:Q89693629-E5E77447-2CC6-4DC4-9807-E3354366C93C
wdt:P1433
wd:Q22079683
p:P356
wds:Q89693629-11695296-526D-4615-B949-BFE7195F1920
wdtn:P356
n9:JAMAONCOL.2019.6650
wdt:P356
10.1001/JAMAONCOL.2019.6650
p:P932
wds:Q89693629-DC3CB9FD-A95D-4EFD-8D82-EF8D8CE20636
wdt:P932
7058271